A new campaign, “Aria di vita” (Breath of Life), launched in Rome this week, aims to give voice to the experiences of those living with pulmonary arterial hypertension (PAH) through the power of music. The initiative, spearheaded by MSD Italia with the support of patient associations Amip and Aipi, seeks to raise awareness of this rare and often misdiagnosed condition and to offer a message of hope to those affected.
Pulmonary arterial hypertension is a progressive and debilitating disease that affects the arteries in the lungs and the right side of the heart. Approximately 3,500 people in Italy are currently living with PAH, with women disproportionately affected, according to campaign organizers. The condition often presents with nonspecific symptoms like shortness of breath and fatigue, leading to delays in diagnosis – sometimes exceeding two years from the onset of initial symptoms. Early diagnosis is crucial for accessing appropriate treatment and improving patient outcomes.
At the heart of “Aria di vita” is an original musical composition created by maestro Enrico Melozzi, a cellist, composer, and conductor. Melozzi’s work, born from conversations with PAH patients, translates the emotional and physical realities of living with the disease into a powerful and moving soundscape. The campaign’s launch featured the unveiling of “Note di vita” (Notes of Life), a large-scale saxophone sculpture created using 3D printing technology. This striking artwork, built from a key instrument used in Melozzi’s composition, will travel to Rome, Bologna, and Milan, offering the public an opportunity to listen to the music and learn more about PAH.
The Challenges of Diagnosis and Treatment
Roberto Badagliacca, Associate Professor and Head of the Cardiology Intensive Care Unit at the Sapienza University of Rome, emphasized the diagnostic hurdles associated with PAH. “Pulmonary arterial hypertension is characterized by increased blood pressure in the pulmonary arteries, placing a significant strain on the right side of the heart,” he explained. “Because its symptoms can mimic other cardiac or pulmonary conditions, diagnosis is often delayed.” Sapienza University of Rome is a leading research institution in cardiovascular health.
Historically, lung or heart-lung transplantation was the only viable option for PAH patients. However, significant advancements in pharmaceutical treatments have dramatically altered the landscape. “Today, we have a wider range of medications that can improve symptoms, slow disease progression, and increase survival,” Badagliacca noted. These therapies include vasodilators and newer drugs that target the underlying biological mechanisms of the disease, offering a more nuanced and effective approach to care.
Giving Voice to the Invisible Illness
The patient associations Amip and Aipi played a central role in shaping the “Aria di vita” campaign, sharing the lived experiences of individuals with PAH. Vittorio Vivenzio, President of Amip, highlighted the often-invisible nature of the condition. “PAH is a disease that often remains unseen by others, but it profoundly impacts the daily lives of patients,” he said. “Initiatives like this are important because they help raise awareness, reduce feelings of isolation, and advocate for the needs of patients, emphasizing the importance of early diagnosis, timely care, and appropriate treatment.”
Marika Gattus, a member of the Aipi board, echoed this sentiment, describing the daily struggle for breath as a central challenge for those living with PAH. “For those of us with pulmonary arterial hypertension, each breath is a daily achievement,” she stated. “The journey from initial diagnosis – which is often delayed – to receiving care is long and complex. ‘Aria di vita’ powerfully captures this reality, communicating both the difficulties and the hope that comes with scientific progress.”
Music as a Bridge to Understanding
Maestro Melozzi described his process of translating patient stories into music. “In recent months, thanks to the patient associations Aipi and Amip, I had the opportunity to listen to intense, fragile, and courageous stories,” he shared. “Stories of people for whom every breath is a challenge and daily life is an obstacle course. But behind this struggle, there is also extraordinary human strength. So I composed this music: so that every instrument tells a nuance of life, every voice in the choir a breath of hope.”
The resulting composition, also titled “Aria di vita,” is a blend of wind, string, and choral elements designed to evoke the emotional and physical realities of PAH. Melozzi hopes the music will encourage listeners to connect with the experiences of those living with the disease and to recognize the resilience of the human spirit. The full track is available on MSD Italia’s social media channels and on the Informati per la vita website, which also features videos, in-depth information, and resources for patients and their families.
Nicoletta Luppi, President and CEO of MSD Italia, underscored the company’s commitment to raising awareness and improving the lives of people with rare diseases. “Promoting awareness and providing accurate information are fundamental pillars of our company’s mission to save and improve lives,” she said. “Using the universal language of music, we aim to give voice to the experiences of those living with pulmonary arterial hypertension and to shine a spotlight on this rare, little-known condition.”
The “Note di vita” sculpture will be on display at Rome’s Termini Station (Galleria Gommata, Via Marsala side) from March 27-29, then move to Piazza Galvani in Bologna (April 3-5), and finally to Piazza Elsa Morante in Milan’s City Life district (April 10-12). These public installations will provide opportunities for the public to engage with the campaign and learn more about PAH.
Disclaimer: This article provides information about pulmonary arterial hypertension and a related awareness campaign. It is not intended to provide medical advice. Please consult with a qualified healthcare professional for diagnosis and treatment of any medical condition.
The “Aria di vita” campaign represents a significant step towards increasing understanding and support for individuals living with pulmonary arterial hypertension. As the sculpture travels to new cities, and the music reaches wider audiences, the hope is to foster a greater sense of empathy and to accelerate progress towards improved diagnosis, treatment, and quality of life for those affected by this challenging condition. Share your thoughts and experiences in the comments below.
Keep reading
